Knight Capital Group’s Perspective Therapeutics CATX Stock Holding History

Knight Capital Group’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$8K	Buy	+1,674	New	+$9.03K	﹤0.01%	3219

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAG

Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CWM

Concert Wealth Management San Jose, California $24.7M AUM 14.91% 1-Year Est. Return

SFSIG

San Francisco Sentry Investment Group San Francisco, California $192M AUM 276.26% 1-Year Est. Return

IFS

Ifrah Financial Services Little Rock, Arkansas $378M AUM 17.57% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Knight Capital Group's CATX Position: Q2 2013 in Review

Knight Capital Group opened a new position in Perspective Therapeutics (CATX) in Q2 2013: 1,674 shares worth $8K. The stake represents ﹤0.01% of the portfolio and ranks #3219 among its holdings.

16 funds tracked by Wall St. Rank hold CATX as of Q2 2013.

Knight Capital Group held 1,674 shares of Perspective Therapeutics worth $8K as of Q2 2013.
Perspective Therapeutics was a new Knight Capital Group position in Q2 2013.
Perspective Therapeutics made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3219 holding.
16 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.